{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T17:55:45Z","timestamp":1770227745883,"version":"3.49.0"},"reference-count":7,"publisher":"Galenos Yayinevi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mirt"],"DOI":"10.4274\/mirt.galenos.2026.28863","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T14:21:21Z","timestamp":1770128481000},"source":"Crossref","is-referenced-by-count":0,"title":["First Southeast Asian Experience of Terbium-161 PSMA Therapy for Metastatic Castration-Resistant Prostate Cancer (mCRPC): Quantitative Imaging and Dosimetric Approach"],"prefix":"10.4274","author":[{"given":"Sasithorn","family":"Amnuaywattakorn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Putthiporn","family":"Charoenphun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Touch","family":"Ativitavas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panya","family":"Pasawang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kitiwat","family":"Khamwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thonnapong","family":"Thongpraparn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjapa","family":"Khiewvan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ponkittiya","family":"Ruangma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wichana","family":"Chamroonrat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krisanat","family":"Chuamsaamarkkee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2811","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.7150\/thno.92273","article-title":"[161Tb]Tb-PSMA-617 radioligand therapy in patients with mCRPC: preliminary dosimetry results and intra-individual head-to-head comparison to [177Lu]Lu-PSMA-617","volume":"14","author":"Schaefer-Schuler","year":"2024","unstructured":"1. Schaefer-Schuler A, Burgard C, Blickle A, Maus S, Petrescu C, Petto S, Barthol-om\u00e4 M, Stemler T, Ezziddin S, Rosar F. [161Tb]Tb-PSMA-617 radioligand therapy in patients with mCRPC: preliminary dosimetry results and intra-individual head-to-head comparison to [177Lu]Lu-PSMA-617. Theranostics. 2024;14:1829-1840.","journal-title":"Theranostics"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Buteau JP, Kostos L, Alipour R, Jackson P, McInstosh L, Emmerson B, Haskali MB, Xie J, Medhurst E, Ravi R, Gonzalez BD, Fettke H, Blyth B, Furic L, Owen K, Sandhu S, Murphy DG, Azad AA, Hofman MS. Clinical trial protocol for VIOLET: a single-center, phase I\/II trial evaluation of radioligand treatment in patients with meta-static castration-resistant prostate cancer with [161Tb]Tb-PSMA-I&T. J Nucl Med. 202;65:1231-1238.","DOI":"10.2967\/jnumed.124.267650"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.cpet.2024.03.006","article-title":"Alpha and beta radiation for theragnostics","volume":"19","author":"Song","year":"2024","unstructured":"3. Song H, Sgouros G. Alpha and beta radiation for theragnostics. PET Clin. 2024;19:307-323.","journal-title":"PET Clin"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.2967\/jnumed.122.265291","article-title":"161Tb-PSMA radioligand therapy: first-in-humans SPECT\/CT Imaging","volume":"64","author":"Al-Ibraheem","year":"2023","unstructured":"4. Al-Ibraheem A, Doudeen RM, Juaidi D, Abufara A, Maus S. 161Tb-PSMA radioligand therapy: first-in-humans SPECT\/CT Imaging. J Nucl Med. 2023;64:1322-1323.","journal-title":"J Nucl Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.3390\/cancers16111974","article-title":"From despair to hope: first Arabic experience of 177Lu-PSMA and 161Tb-PSMA ther-apy for metastatic castration-resistant prostate cancer","volume":"16","author":"Al-Ibraheem","year":"2024","unstructured":"5. Al-Ibraheem A, Abdlkadir AS, Sweedat DA, Maus S, Al-Rasheed U, Salah S, Khriesh F, Juaidi D, Abu Dayek D, Istatieh F, Anwar F, Asrawi A, Abufara A, Al-Rwashdeh M, Abu-Hijlih R, Sharaf B, Ghanem R, Abdel-Razeq H, Mansour A. From despair to hope: first Arabic experience of 177Lu-PSMA and 161Tb-PSMA ther-apy for metastatic castration-resistant prostate cancer. Cancers (Basel). 2024;16:1974.","journal-title":"Cancers (Basel)"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"5979","DOI":"10.1007\/s10967-025-10352-3","article-title":"Terbium-161 PSMA therapy in mCRPC patient based on an optimized radiolabeling protocol","volume":"334","author":"Sezgin","year":"2025","unstructured":"6. Sezgin C, Uygur E, Parlak Y, Karatay B, Barutca S, Dirican A, et al. Terbium-161 PSMA therapy in mCRPC patient based on an optimized radiolabeling protocol. Journal of Radioanalytical and Nuclear Chemistry. 2025;334:5979.","journal-title":"Journal of Radioanalytical and Nuclear Chemistry"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. K\u00fc\u00e7\u00fck N\u00d6, Co\u015fkun N, Araz M, Alan Selcuk N, Berberoglu K, Ozdemir EC, G\u00fcm\u00fc\u015fer FG, Kuyumcu S, Sezgin C, Sanli O, Sanli Y, Sendur MAN, Urun Y. Initial multicenter experience with [161Tb]Tb-PSMA in [177Lu]Lu-PSMA-refractory met-astatic castration-resistant prostate cancer: preliminary results. Nucl Med Semin. 2025;12:1921-1926.","DOI":"10.2967\/jnumed.125.270952"}],"container-title":["Molecular Imaging and Radionuclide Therapy"],"original-title":[],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T06:08:51Z","timestamp":1770185331000},"score":1,"resource":{"primary":{"URL":"https:\/\/mirt.tsnmjournals.org\/articles\/first-southeast-asian-experience-of-terbium-161-psma-therapy-for-metastatic-castration-resistant-prostate-cancer-mcrpc-quantitative-imaging-and-dosimetric-approach\/doi\/mirt.galenos.2026.28863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":7,"URL":"https:\/\/doi.org\/10.4274\/mirt.galenos.2026.28863","relation":{},"ISSN":["2146-1414","2147-1959"],"issn-type":[{"value":"2146-1414","type":"print"},{"value":"2147-1959","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]}}}